RESPONSE OF PRIMARY THORACIC DISEASE TO CHEMORADIOTHERAPY CORRELATES WITH BRAIN-METASTASIS FREE SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT

被引：0
|
作者：
Manapov, F. [1 ]
Kloecking, S. [2 ]
Niyazi, M. [1 ]
Levitskiy, V. [2 ]
Belka, C. [1 ]
Hildebrandt, G. [2 ]
Fietkau, R. [3 ]
Klautke, G. [3 ]
机构：
[1] Univ Klinikum Munchen, Munich, Germany
[2] Univ Klinikum Rostock, Rostock, Germany
[3] Univ Klinikum Erlangen Nurnberg, Erlangen, Germany
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 43 条
  • [1] CHEMORADIOTHERAPY DURATION CORRELATES WITH OVERALL SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Belka, C.
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    LUNG CANCER, 2011, 71 : S35 - S35
  • [2] Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
    Manapov, Farkhad
    Kloecking, Sabine
    Niyazi, Maximilian
    Levitskiy, Victor
    Belka, Claus
    Hildebrandt, Guido
    Fietkau, Rainer
    Klautke, Gunther
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 309 - 314
  • [3] Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
    Farkhad Manapov
    Sabine Klöcking
    Maximilian Niyazi
    Victor Levitskiy
    Claus Belka
    Guido Hildebrandt
    Rainer Fietkau
    Gunther Klautke
    Journal of Neuro-Oncology, 2012, 109 : 309 - 314
  • [4] Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Belka, C.
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (01) : 29 - 34
  • [5] TIME TO TREATMENT FAILURE IN LIMITED DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO RESPONDED TO CHEMORADIOTHERAPY
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Belka, C.
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S79 - S79
  • [6] Time to treatment failure in limited disease small-cell lung cancer patients with poor initial performance status who responded to chemoradiotherapy
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Belka, C.
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 97 - 97
  • [7] The Response of the Primary tumor to Chemoradiotherapy correlates with brain metastasis-free Survival in Patients with small cell Lung cancer in Stage "Limited disease " with initially poor Performance Status after successful completion of multimodal Therapy
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Levitskiy, V
    Belka, C.
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 67 - 67
  • [8] SUBGROUP ANALYSIS OF OVERALL SURVIVAL ACCORDING TO THE DURATION OF CHEMORADIOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG CANCER PATIENTS WHO RESPONDED TO MULTIMODALITY TREATMENT
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Hildebrandt, G.
    Belka, C.
    Fietkau, R.
    Klautke, G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S80 - S80
  • [9] Subgroup analysis of overall survival according to the duration of chemoradiotherapy in limited disease small-cell lung cancer patients who responded to multimodality treatment
    Manapov, F.
    Kloecking, S.
    Niyazi, M.
    Belka, C.
    Levitskiy, V
    Hildebrandt, G.
    Fietkau, R.
    Klautke, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 97 - 97
  • [10] Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older
    Shukuya, Takehito
    Takahashi, Toshiaki
    Harada, Hideyuki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Kazuhisa
    Yamamoto, Nobuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 176 - 183
12345